ArTS Archivio della ricerca di Trieste

Crocè, Saveria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.737
EU - Europa 7.953
AS - Asia 7.570
SA - Sud America 1.002
Continente sconosciuto - Info sul continente non disponibili 763
AF - Africa 280
OC - Oceania 25
Totale 32.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.308
SG - Singapore 2.705
IT - Italia 2.170
CN - Cina 1.634
PL - Polonia 1.248
SE - Svezia 849
VN - Vietnam 828
HK - Hong Kong 796
BR - Brasile 753
DE - Germania 667
UA - Ucraina 615
KR - Corea 424
FR - Francia 392
GB - Regno Unito 390
BD - Bangladesh 369
FI - Finlandia 345
RU - Federazione Russa 283
CA - Canada 251
NL - Olanda 226
BG - Bulgaria 199
TR - Turchia 196
IE - Irlanda 177
IN - India 167
AR - Argentina 95
MX - Messico 88
MA - Marocco 72
CH - Svizzera 68
IQ - Iraq 58
ES - Italia 57
SN - Senegal 57
BE - Belgio 51
JP - Giappone 49
PK - Pakistan 47
ZA - Sudafrica 46
ID - Indonesia 39
AT - Austria 38
EC - Ecuador 38
EG - Egitto 34
PH - Filippine 31
SA - Arabia Saudita 29
CO - Colombia 27
CZ - Repubblica Ceca 26
LT - Lituania 26
RO - Romania 24
CL - Cile 21
PY - Paraguay 20
UZ - Uzbekistan 20
KE - Kenya 19
AU - Australia 18
CR - Costa Rica 18
IL - Israele 18
IR - Iran 18
VE - Venezuela 17
DK - Danimarca 16
TH - Thailandia 13
MY - Malesia 12
AZ - Azerbaigian 11
GR - Grecia 11
HR - Croazia 11
BO - Bolivia 10
EU - Europa 10
JO - Giordania 10
KZ - Kazakistan 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
DZ - Algeria 9
ET - Etiopia 9
GT - Guatemala 9
HN - Honduras 9
NI - Nicaragua 9
PE - Perù 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
LK - Sri Lanka 8
NP - Nepal 8
TW - Taiwan 8
JM - Giamaica 7
KG - Kirghizistan 7
PA - Panama 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
LB - Libano 6
OM - Oman 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
GE - Georgia 5
HU - Ungheria 5
NG - Nigeria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
SI - Slovenia 5
BZ - Belize 4
MT - Malta 4
RS - Serbia 4
SY - Repubblica araba siriana 4
BA - Bosnia-Erzegovina 3
EE - Estonia 3
Totale 31.521
Salva come PNG Salva come JPEG
Città #
Ashburn 1.586
Singapore 1.505
Warsaw 1.077
Woodbridge 969
San Jose 950
Fairfield 934
Ann Arbor 875
Houston 852
Chandler 828
Hong Kong 772
Jacksonville 560
Trieste 482
Wilmington 459
Seattle 437
Council Bluffs 414
Seoul 407
Hefei 389
Beijing 383
Cambridge 304
Boardman 262
Princeton 260
Ho Chi Minh City 252
Chicago 242
Los Angeles 233
Columbus 227
Dallas 195
Milan 193
Sofia 193
Hanoi 190
Dublin 168
Santa Clara 160
Lauterbourg 157
London 153
Izmir 151
Zgierz 143
New York 136
Toronto 129
The Dalles 124
Munich 121
Frankfurt am Main 108
Moscow 106
Buffalo 104
Helsinki 101
Atlanta 96
Rome 94
Dearborn 79
São Paulo 72
San Diego 67
Phoenix 62
Falls Church 58
Dakar 57
Casablanca 56
Düsseldorf 56
Bern 52
Orem 49
Turku 49
Montreal 48
Brussels 45
Venezia 42
Dong Ket 40
Redmond 40
Amsterdam 39
Des Moines 39
Redwood City 38
Venice 36
Denver 35
Udine 35
Nuremberg 34
Tokyo 33
Da Nang 32
Guangzhou 31
Mexico City 31
Naples 31
Redondo Beach 31
Vienna 31
Boston 30
Haiphong 29
Krefeld 29
Shanghai 29
Stockholm 29
Chennai 28
San Francisco 28
Verona 28
Brooklyn 27
Mumbai 26
Rio de Janeiro 26
Turin 25
Washington 24
Baghdad 22
Dhaka 22
Miami 22
Miano 22
Bremen 21
Grafing 20
Jinan 20
Johannesburg 20
Belo Horizonte 19
Lappeenranta 19
Mestre 19
Norwalk 19
Totale 20.432
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 498
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 441
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 422
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 416
Adverse reactions of direct-acting antiviral agents in HCV patients: Our experience 401
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography 400
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 397
The Role of Liver and Spleen Elastography in the Screening of Esophageal Varices in Patients with Liver Cirrhosis: Do We Really Need Endoscopy? 390
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 367
Gut microbiota characterisation in obese patients before and after bariatric surgery 363
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 339
Anatomy of Basal Ganglia and Thalamus 322
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 280
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 278
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis 276
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 272
Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. 265
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 261
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 261
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 260
Diverticular Disease and Rifaximin: An Evidence-Based Review 258
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 257
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 255
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression 255
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 250
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 247
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 246
Semi-automatic Approach to Estimate the Degree of Non-alcoholic Fatty Liver Disease (NAFLD) from Ultrasound Images 245
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 242
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 238
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 236
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study 234
Aspirin and Infection: A Narrative Review 224
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 220
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 219
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature 218
Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue and liver diseases 213
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 213
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 213
Assessing the feasibility of AI-based Hamaguchi score estimation for NAFLD diagnosis using ultrasound images 211
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 211
Visual impairments and attention in parkinson's disease 211
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 211
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 210
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 208
A story of liver and gut microbes: How does the intestinal flora affect liver disease? A review of the literature 207
Predicting response to non-selective beta-blockers with liver–spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices 206
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy 206
Stem cells in the development of hepatocellular carcinoma: identification and expression 204
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 203
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients 202
Cross talk between multipotent stem-like cells and cancer cells in hepatocellular carcinoma 200
Spontaneous rectal perforation in a patient with SARS–CoV-2 infection 199
Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature 198
Treatment options in Western hepatocellular carcinoma: A prospective study of 224 patients 197
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 197
Analysis of p53 and ras gene mutations in hepatocellular carcinoma from a Western country 195
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 192
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19 192
Deep brain stimulation of the subthalamus: Neuropsychological effects 190
Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery 187
Evaluation with contrast enhanced US of perfusion changes in untreatable hepatocellular carcinoma after thalidomide administration: preliminary results 184
PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis 183
PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY 182
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 178
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. 2009 Oc FI, 9;9:75. 177
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 177
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 175
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 173
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1 171
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 171
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 170
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test 169
Antibody pattern of HCV infection and hepatocellular carcinoma in Itakly: A case control study 168
Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience 165
Clinical update on non-alcoholic fatty liver disease and steatohepatitis 165
Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents 165
Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections 164
Pylephlebitis: A Systematic Review on Etiology, Diagnosis, and Treatment of Infective Portal Vein Thrombosis 164
Optimization of hepatological clinical guidelines interpretation by large language models: a retrieval augmented generation-based framework 163
Circulatory mirna as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma 161
Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation 158
Characterization of focal liver lesions by pulse inversion harmonic imaging (PIHI) with Levovist in patients with cirrhosis. 157
MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View 157
Cirrosi biliare primitiva (CBP) asintomatica: trattamento con acido ursidesossicolico (UDCA). Risultati preliminari dopo 12 mesi. 156
The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma 155
Severity of liver disease with different hepatitis C viral clones. 154
Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension 153
Clinical and virological features of acute HBV-related hepatitis in southern vietnam 152
Spontaneous porto-femoral shunting in long-standing portal hypertension 152
null 146
One pot synthesis of UiO-66-NH2 containing curcumin and cytotoxic evaluation toward liver cancer cells 145
Incidence and natural history of hepatocellular carcinoma and liver cirrhosis in Italy. A lesson from Trieste 145
null 143
Intravenous Fosfomycin for Difficult-to-Treat Infections: A Real-Life Multicentric Study in Italy 139
Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients 139
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study 139
The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations 139
Advanced Non-linear Modeling and Explainable Artificial Intelligence Techniques for Predicting 30-Day Complications in Bariatric Surgery: A Single-Center Study 136
Incisional hernia by liver cysts 135
Totale 22.054
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.710 0 0 226 204 58 133 103 126 213 167 103 377
2022/20232.513 216 280 167 346 224 454 55 263 321 38 96 53
2023/20241.574 116 90 73 101 171 135 270 314 30 50 130 94
2024/20253.989 64 71 256 385 356 371 337 195 507 528 425 494
2025/202611.229 1.274 589 731 983 1.019 942 1.589 375 1.169 1.446 623 489
2026/20271.627 466 691 470 0 0 0 0 0 0 0 0 0
Totale 32.330